Reported about 3 hours ago
Hims & Hers Health's stock has surged following news that the FDA is reconsidering its restrictions on compounded weight-loss drugs, which are custom medications blending various ingredients. Experts discuss these developments and their implications on today's Market Domination.
Source: YAHOO